Natalie Wuliji, DO

Dr. Natalie Wuliji is a board-certified hematologist-oncologist with a clinical and research focus on autoimmune diseases. She has specialized training in bone marrow transplantation and cellular therapy, which she applies to implementation of immune-based therapeutic strategies. She serves as principal and sub-investigator on clinical trials involving CAR T-cell therapy for autoimmune conditions, contributing to trial design, patient evaluation, and the coordination of early-phase cell therapy trials with their unique safety and operational requirements. Dr. Wuliji is a member of the American Society of Hematology and the American Society of Transplantation and Cellular Therapy.